Literature DB >> 1370702

Superoxide anion production by rat neutrophils at various stages of bleomycin-induced lung injury.

E B Tarnell1, B L Oliver, G M Johnson, F L Watts, R S Thrall.   

Abstract

This study investigated the level of activation of neutrophils isolated from rats at various stages of bleomycin-induced lung injury. Neutrophils were collected from blood and bronchoalveolar lavage (BAL) fluid and their superoxide anion (O2-)-generating capacity measured in response to phorbol myristate acetate (PMA) and opsonized zymosan (OZ) stimulation. When stimulated with PMA, BAL neutrophils isolated from animals 3 days after bleomycin treatment had a significantly greater capacity to produce O2- than BAL neutrophils from animals 7 days after bleomycin treatment. The O2- levels of 7 day BAL neutrophils more closely resembled the resting levels obtained with circulating neutrophils from both control and bleomycin-treated animals. There were no differences observed in any of the neutrophils when stimulated with OZ. Myeloperoxidase levels were measured in plasma and BAL and found to be elevated only in plasma at 7 days after bleomycin. These data demonstrate that neutrophil activation does occur in this model and that the activation appears to be transient, in response to specific stimuli and compartmentalized between the lung and blood.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370702     DOI: 10.1007/bf00164754

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  40 in total

Review 1.  The biology and pathology of oxygen radicals.

Authors:  J M McCord; I Fridovich
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

2.  Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B.

Authors:  P M Henson; B Zanolari; N A Schwartzman; S R Hong
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

3.  Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system.

Authors:  H J Cohen; M E Chovaniec
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

4.  Bleomycin-induced interstitial pneumonia in dogs.

Authors:  R W Fleischman; J R Baker; G R Thompson; U H Schaeppi; V R Illievski; D A Cooney; R D Davis
Journal:  Thorax       Date:  1971-11       Impact factor: 9.139

5.  Oxidant activity in expired breath of patients with adult respiratory distress syndrome.

Authors:  S R Baldwin; R H Simon; C M Grum; L H Ketai; L A Boxer; L J Devall
Journal:  Lancet       Date:  1986-01-04       Impact factor: 79.321

Review 6.  Pulmonary effects of radiation therapy.

Authors:  N J Gross
Journal:  Ann Intern Med       Date:  1977-01       Impact factor: 25.391

7.  Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied.

Authors:  G L Snider; B R Celli; R H Goldstein; J J O'Brien; E C Lucey
Journal:  Am Rev Respir Dis       Date:  1978-02

8.  Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria.

Authors:  B A Freeman; J D Crapo
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

9.  The alteration of superoxide dismutase, catalase, glutathione peroxidase, and NAD(P)H cytochrome c reductase in guinea pig polymorphonuclear leukocytes and alveolar macrophages during hyperoxia.

Authors:  M Rister; R L Baehner
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

10.  The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.

Authors:  I Y Adamson; D H Bowden
Journal:  Am J Pathol       Date:  1974-11       Impact factor: 4.307

View more
  9 in total

1.  Time course of bleomycin-induced lung fibrosis.

Authors:  G Izbicki; M J Segel; T G Christensen; M W Conner; R Breuer
Journal:  Int J Exp Pathol       Date:  2002-06       Impact factor: 1.925

2.  Magnolol reduces bleomycin-induced rodent lung fibrosis.

Authors:  Xiangfeng Zhang; Han Huang; Huijuan Chang; Xiuhong Jin
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Comprehensive lung injury pathology induced by mTOR inhibitors.

Authors:  Guadalupe Aparicio; Moisés B Calvo; Vanessa Medina; Ovidio Fernández; Paula Jiménez; Martina Lema; Angélica Figueroa; Luis M Antón Aparicio
Journal:  Clin Transl Oncol       Date:  2009-08       Impact factor: 3.405

4.  Peplomycin, a bleomycin derivative, induces myofibroblasts in pulmonary fibrosis.

Authors:  T Osaki; K Yoneda; Y Tatemoto; T Yamamoto; T Yokoyama; H Enzan
Journal:  Int J Exp Pathol       Date:  2001-08       Impact factor: 1.925

Review 5.  The effects of apigenin administration on the inhibition of inflammatory responses and oxidative stress in the lung injury models: a systematic review and meta-analysis of preclinical evidence.

Authors:  Ali Rahimi; Mina Alimohammadi; Fatemeh Faramarzi; Reza Alizadeh-Navaei; Alireza Rafiei
Journal:  Inflammopharmacology       Date:  2022-06-04       Impact factor: 5.093

Review 6.  Extracellular superoxide dismutase in pulmonary fibrosis.

Authors:  Fei Gao; Vuokko L Kinnula; Marjukka Myllärniemi; Tim D Oury
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

7.  Contrasting influence of peplomycin and azelastine hydrochloride (Azeptin) on reactive oxygen generation in polymorphonuclear leukocytes, cytokine generation in lymphocytes, and collagen synthesis in fibroblasts.

Authors:  E Ueta; T Osaki; K Yoneda; T Yamamoto
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Apigenin protects against bleomycin-induced lung fibrosis in rats.

Authors:  Ling Chen; Wei Zhao
Journal:  Exp Ther Med       Date:  2015-11-20       Impact factor: 2.447

9.  Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.

Authors:  Ksenija Bernau; Caitlyn Ngam; Elizabeth E Torr; Benjamin Acton; Jacob Kach; Nickolai O Dulin; Nathan Sandbo
Journal:  Respir Res       Date:  2015-03-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.